Sign up to save your podcasts
Or
Share Inside the Issue: The Current and Future Role of CD20 x CD3 Bispecific Antibodies in the Management of Non-Hodgkin Lymphoma
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Inside the Issue: The Current and Future Role of CD20 x CD3 Bispecific Antibodies in the Management of Non-Hodgkin Lymphoma
Dr Martin Hutchings from Rigshospitalet, Copenhagen University Hospital in Copenhagen, Denmark, and Dr Loretta Nastoupil from The University of Texas MD Anderson Cancer Center in Houston, Texas, discuss the current and future role of CD20 x CD3 bispecific antibodies in the management of non-Hodgkin lymphoma.
View all episodes
By Dr. Neil Love
4.4
7272 ratings
Dr Martin Hutchings from Rigshospitalet, Copenhagen University Hospital in Copenhagen, Denmark, and Dr Loretta Nastoupil from The University of Texas MD Anderson Cancer Center in Houston, Texas, discuss the current and future role of CD20 x CD3 bispecific antibodies in the management of non-Hodgkin lymphoma.
More shows like Hematologic Oncology Update
View all
NEJM This Week
321 Listeners
JAMA Clinical Reviews
495 Listeners
Breast Cancer Update
66 Listeners
Lung Cancer Update
31 Listeners
Prostate Cancer Update
14 Listeners
Gastrointestinal Cancer Update
17 Listeners
Gynecologic Oncology Update
12 Listeners
Dermatologic Oncology Update
0 Listeners
Research To Practice | Oncology Videos
115 Listeners
The Hematologist
26 Listeners
Mayo Clinic Talks
292 Listeners
The Curbsiders Internal Medicine Podcast
3,331 Listeners
The ONS Podcast
197 Listeners
Blood Podcast
54 Listeners
Oncology Today with Dr Neil Love
57 Listeners
Blood Cancer Talks
48 Listeners
Two Onc Docs
189 Listeners
WolverHeme Happy Hour
30 Listeners
Oncology Nursing Update with Dr Neil Love: Focus on Oncology Nursing
0 Listeners